S. Bartram

MALDI-MS and colorimetric analysis of diisocyanate and polyol migrants from model polyurethane adhesives used in food packaging.

G. Lawson, S. Bartram, S. Fitchner, 2000, The Analyst.

Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.

G. Murphy, T. Cawston, S. Bartram, 2001, Annals of the rheumatic diseases.

Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.

R. Francis, D. Walshaw, N. Thompson, 2006, World journal of gastroenterology.

Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn’s disease

J. Mansfield, R. Francis, C. Todhunter, 2005, Gut.

Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases.

Antoni B. Chan, I. Bruce, C. Gordon, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Bone mineral density and juvenile chronic arthritis: comment on the article by Zak et al.

R. Francis, H. Foster, S. Bartram, 2000, Arthritis and rheumatism.

Experience with methotrexate-associated pneumonitis in northeastern England: comment on the article by Kremer et al.

S. Bartram, 1998, Arthritis and rheumatism.

A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease

D. Rawlings, S. Bartram, R. Peaston, 2003, Alimentary pharmacology & therapeutics.

The Fragment as a Manifestation of Non-Finito in Auguste Rodin’s Oeuvre

S. Bartram, 2016 .

AB0632B TB OR NOT TB, THAT IS THE VASCULITIC QUESTION

S. Bartram, S. Khalid, 2019, Abstracts accepted for Publication.

002 Biopsy proven giant cell arteritis in a patient with psoriatic arthritis on TNF-alpha inhibitor treated with high dose prednisolone and a switch to secukinumab (anti IL-17)

L. Sammut, A. Litwic, S. Bartram, 2018 .